Table 3.
Multivariate analysis of transplant outcomes according to donor type
| Outcome | MSD | MUD | Haplo | ||||
|---|---|---|---|---|---|---|---|
| Reference | HR | 95% CI | p | HR | 95% CI | p | |
| Acute GvHD grade II–IV | 1 | 1.25 | 0.73–2.13 | 0.4 | 0.99 | 0.62–1.57 | 1 |
| Overall chronic GvHD | 1 | 1.84 | 1.02–3.34 | 0.04 | 1.03 | 0.59–1.79 | 0.9 |
| NRM | 1 | 1.06 | 0.47–2.38 | 0.9 | 1.16 | 0.60–2.25 | 0.7 |
| RI | 1 | 0.78 | 0.38–1.57 | 0.5 | 0.74 | 0.43–1.28 | 0.3 |
| LFS | 1 | 0.91 | 0.54–1.55 | 0.7 | 0.91 | 0.59–1.39 | 0.7 |
| OS | 1 | 1.05 | 0.57–1.94 | 0.9 | 1.13 | 0.68–1.86 | 0.6 |
| GRFS | 1 | 1.02 | 0.65–1.59 | 0.9 | 0.96 | 0.66–1.4 | 0.8 |
GvHD, graft-versus-host disease; HR, hazard ratio; CI, confidence interval; p, p value; NRM, non-relapse mortality; RI, relapse incidence; LFS, leukemia-free survival; OS, overall survival; GRFS, graft-versus-host disease-free, relapse-free survival; MSD, matched sibling donor; MUD, matched unrelated donor; Haplo, haploidentical donor